Published Online:
June 16, 2010
This Cochrane Review is at the protocol stage and there is no abstract or plain language summary. The objectives for the review are as follows:
We will assess the clinical effectiveness and safety of second-line chemotherapy for treating women with ovarian cancer sensitive or resistant to a previous course of platinum-based chemotherapy.